Old Web
English
Sign In
Acemap
>
authorDetail
>
W. Haazen
W. Haazen
Medicine
Protease
Genotype
Pharmacokinetics
Virology
3
Papers
17
Citations
0.00
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (3)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
DOP070 The FFA2 antagonist GLPG0974: opportunity to treat neutrophil-driven inflammation
2014
Journal of Crohns & Colitis
Frédéric Vanhoutte
Florence Namour
S. Dupont
W. Haazen
M. Petkova
A Van der Aa
G. van't Klooster
Johan Beetens
Show All
Source
Cite
Save
Citations (1)
458 FINAL RESULTS OF THE PHARMACOKINETICS, EFFICACY, AND SAFETY/TOLERABILITY OF 400 AND 600 MG ONCE-DAILY DOSING OF ACH-1625 (HCV NS3 PROTEASE INHIBITOR) IN HCV GENOTYPE 1
2011
Journal of Hepatology
V. Detishin
W. Haazen
R. Hooijmaijers
M. Ruppert
K. Bol
H. Robison
L. Robarge
Atul Agarwal
Milind Deshpande
E. Olek
Show All
Source
Cite
Save
Citations (6)
2012 VIROLOGICAL RESPONSE, SAFETY, AND PHARMACOKINETIC PROFILE FOLLOWING SINGLE- AND MULTIPLE-DOSE ADMINISTRATION OF ACH-0141625 PROTEASE INHIBITOR TO HEALTHY VOLUNTEERS AND HCV GENOTYPE-1 PATIENTS
2010
Journal of Hepatology
V. Detishin
W. Haazen
H. Robison
L. Robarge
E. Olek
Show All
Source
Cite
Save
Citations (10)
1